Utility of Coagulation Markers for the Prediction of Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis.


Journal

Lung
ISSN: 1432-1750
Titre abrégé: Lung
Pays: United States
ID NLM: 7701875

Informations de publication

Date de publication:
08 2019
Historique:
received: 14 02 2019
accepted: 17 06 2019
pubmed: 27 6 2019
medline: 9 4 2020
entrez: 27 6 2019
Statut: ppublish

Résumé

We aimed to evaluate the utility of coagulation markers for the prediction of rapidly progressive interstitial lung disease (RP-ILD) in patients with dermatomyositis (DM). In this retrospective study, 29 patients with DM-associated ILD were analyzed. The number of patients with RP-ILD was 15 (52%). The baseline clinical and demographic data and laboratory markers were analyzed to identify predictive factors for RP-ILD.The univariate logistic regression analysis demonstrated that in addition to well-known laboratory markers, such as serum ferritin, KL-6, and lymphocyte counts, a prolonged activated partial thromboplastin time (aPTT) ratio at the time of DM-associated ILD diagnosis was useful for predicting RP-ILD. Moreover, the logistic regression model and receiver operating characteristic curve analysis showed that combinations of the aPTT ratio and well-known laboratory markers were significantly effective in predicting RP-ILD. This study suggested that an association between RP-ILD and the coagulation system exists.

Identifiants

pubmed: 31240390
doi: 10.1007/s00408-019-00245-0
pii: 10.1007/s00408-019-00245-0
doi:

Substances chimiques

Biomarkers 0
MUC1 protein, human 0
Mucin-1 0
Ferritins 9007-73-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-442

Références

Pulm Pharmacol Ther. 2014 Dec;29(2):233-40
pubmed: 24836398
Respir Med. 2011 Sep;105(9):1380-7
pubmed: 21632230
Clin Rheumatol. 2016 Jan;35(1):113-6
pubmed: 26660480
Chest. 2005 Sep;128(3):1475-82
pubmed: 16162746
Respir Med. 2017 Jul;128:78-84
pubmed: 28610674
N Engl J Med. 1975 Feb 13;292(7):344-7
pubmed: 1090839
Rheumatology (Oxford). 2010 Jul;49(7):1354-60
pubmed: 20385617
Lab Med. 2017 Nov 8;48(4):295-313
pubmed: 29126301
J Clin Invest. 2012 Aug;122(8):2731-40
pubmed: 22850883
Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75
pubmed: 27299520
Rheumatol Int. 2012 Dec;32(12):3909-15
pubmed: 22198664
Curr Opin Rheumatol. 2010 Nov;22(6):639-43
pubmed: 20827200
Pulm Med. 2011;2011:531302
pubmed: 21637367
Dermatol Clin. 2002 Jul;20(3):387-408
pubmed: 12170874
J Rheumatol. 2006 May;33(5):903-6
pubmed: 16652421
Lung. 2016 Oct;194(5):733-7
pubmed: 27166633
Curr Rheumatol Rep. 2018 Mar 15;20(3):15
pubmed: 29541874

Auteurs

Tomoya Sagawa (T)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Takashi Kida (T)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Tohru Inaba (T)

Department of Infection Control and Laboratory Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Isao Yokota (I)

Department of Biostatistics, Graduate School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, Sapporo, 060-8638, Japan.

Risa Sagawa (R)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Akiko Kasahara (A)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Shunya Kaneshita (S)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Takuya Inoue (T)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Hidetake Nagahara (H)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Kazuki Fujioka (K)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Makoto Wada (M)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Masataka Kohno (M)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.

Yutaka Kawahito (Y)

Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. kawahity@koto.kpu-m.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH